| Practice Changing Highlights in G/GEJ Cancers: The Latest Data from Chicago | | |
| Integrating Clinical Insights: Key G/GEJ Cancer Data Analyzed from the San Diego Oncology Conference | 02/04/2025 | |
| Optimizing Treatment of Metastatic G/GEJ Cancers: Balancing Efficacy and Adverse Effects With Combi… | 02/02/2025 | |
| Navigating Treatment Paths: Selection and Sequencing in Biomarker-Driven Combination Regimens for F… | 02/04/2025 | |
| What Is the Evidence Supporting CLDN18.2 Targeting in Frontline Management of G/GEJ Cancers | 01/30/2025 | |
| Claudin18.2: An Emerging Biomarker and Its Significance as a Therapeutic Target in G/GEJ Cancers | 02/03/2025 | |
| Navigating Challenges in Metastatic Gastric/GEJ Cancer Management: Advancements in Biomarker-Direct… | | |
